CLDX icon

Celldex Therapeutics
CLDX

Overview Fund Activity

158 hedge funds and large institutions have $1.35B invested in Celldex Therapeutics in 2022 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 58 increasing their positions, 38 reducing their positions, and 24 closing their positions.

Holders
158
Holders Change
+2
Holders Change %
+1.28%
% of All Funds
2.73%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.07%
New
26
Increased
58
Reduced
38
Closed
24
Calls
$21.5M
Puts
$10.1M
Net Calls
+$11.4M
Net Calls Change
-$66.9M

Top Buyers

1
Jennison Associates
1
Jennison Associates
New York
$35.8M
2
BG
2
Bellevue Group
Switzerland
$50.6M
3
Marshall Wace
3
Marshall Wace
United Kingdom
$18.3M
4
KCM
4
Kynam Capital Management
New Jersey
$45M
5
Citadel Advisors
5
Citadel Advisors
Florida
$42.2M

Top Sellers

1
Viking Global Investors
1
Viking Global Investors
Connecticut
$0
2
VA
2
VR Adviser
New York
$2.11M
3
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$0
4
VC
4
Vivo Capital
California
$5.59M
5
Morgan Stanley
5
Morgan Stanley
New York
$5.72M
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$197M 7,015,843 +2,699 +0%
State Street
2
State Street
Massachusetts
$89.2M 3,171,578 -57,274 -2%
BlackRock
3
BlackRock
New York
$88M 3,130,413 -21,056 -0.7%
RI
4
RTW Investments
New York
$86.7M 3,084,215 – –
Wellington Management Group
5
Wellington Management Group
Massachusetts
$86.6M 3,080,733 +240,350 +8%
Vanguard Group
6
Vanguard Group
Pennsylvania
$69.6M 2,475,381 +40,009 +2%
RCM
7
RA Capital Management
Massachusetts
$58.3M 2,075,000 – –
RG
8
Redmile Group
California
$55.8M 1,985,151 -85,137 -4%
BG
9
Bellevue Group
Switzerland
$50.6M 1,800,000 +875,000 +95%
EAM
10
Eventide Asset Management
Massachusetts
$50.4M 1,791,800 +346,100 +24%
KCM
11
Kynam Capital Management
New Jersey
$45M 1,600,127 +467,868 +41%
Citadel Advisors
12
Citadel Advisors
Florida
$42.2M 1,501,094 +457,067 +44%
Jennison Associates
13
Jennison Associates
New York
$35.8M 1,274,021 +1,274,021 New
Geode Capital Management
14
Geode Capital Management
Massachusetts
$24M 852,706 +11,582 +1%
OCA
15
Octagon Capital Advisors
New York
$21.4M 761,398 – –
T. Rowe Price Associates
16
T. Rowe Price Associates
Maryland
$21M 746,008 +212,606 +40%
Goldman Sachs
17
Goldman Sachs
New York
$18.7M 664,431 +224,719 +51%
Marshall Wace
18
Marshall Wace
United Kingdom
$18.3M 652,721 +632,698 +3,160%
EP
19
Eversept Partners
New York
$17.6M 626,372 +73,984 +13%
CC
20
Commodore Capital
New York
$15.1M 538,812 – –
Dimensional Fund Advisors
21
Dimensional Fund Advisors
Texas
$15M 534,515 -77,357 -13%
FAM
22
Fred Alger Management
New York
$12.5M 443,642 +200,259 +82%
Northern Trust
23
Northern Trust
Illinois
$11.9M 422,241 -1,426 -0.3%
RSCM
24
Rock Springs Capital Management
Maryland
$11.9M 421,604 +86,127 +26%
CS
25
Candriam SCA
Luxembourg
$11.8M 418,509 +127,715 +44%
1
2 3 4 5